Lv7
3980 积分 2021-12-22 加入
Long‐Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER‐CN Study
11小时前
已完结
Distinct mechanistic features of atrial fibrillation in hypertrophic cardiomyopathy
11小时前
已完结
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy
11小时前
已完结
EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy
11小时前
已完结
Exercise Training and Cardiac Remodeling in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
24天前
已完结
Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort
24天前
已完结
Long-Term Real-World Impact of Cardiac Myosin Inhibitors on Diastolic Function in Hypertrophic Cardiomyopathy Patients
24天前
已完结
Mavacamten Versus Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: An Echocardiography-Derived Pressure-Volume Analysis
24天前
已完结
New and recurrent atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy receiving mavacamten
24天前
已完结
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients
24天前
已完结
皖公网安备34019202002308
